WHITE PAPER mAbs and Their Therapeutic Evolution By Tracy TreDenick, Head of Regulatory and Quality, and Senior Consultant Monoclonal...
Read more
Proteins—especially antibodies—are gaining in popularity in the pharmaceutical industry, both as drugs in their own right and as targeting agents for other drugs. In fact,...
BioTechLogic, Inc., is a biopharmaceutical manufacturing and CMC consulting firm with strategic, practical, and hands-on experience that helps clients bring their products to market quickly and successfully by augmenting and optimizing an organization's technical, manufacturing, analytical, and regulatory resources.
Access our on-demand webinar that discusses proactive quality system management that allow pharmaceutical manufacturers to avoid time and resource-intensive filing approval delays, observations, and warning letters. • Deviation, CAPA & change control management•...
Article originally published on GEN The biotechnology industry achieved many firsts this past year, from the first approved drug that can slow the rates of cognitive and functional decline in adults with Alzheimer’s disease, to the first CRISPR-based gene editing...
© 2024 BIOTECHLOGIC, INC | ALL RIGHTS RESERVED